UVEITIS
Clinical trials for UVEITIS explained in plain language.
Never miss a new study
Get alerted when new UVEITIS trials appear
Sign up with your email to follow new studies for UVEITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with eye inflammation: baricitinib trial shows promise
Disease control OngoingThis study tests whether baricitinib, an oral drug, is safe and effective for children aged 2 to 18 with active uveitis (eye inflammation) linked to juvenile arthritis or a related condition. Participants had not responded well to standard treatments. The main goal is to reduce e…
Matched conditions: UVEITIS
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 22, 2026 12:04 UTC
-
Singapore study dives into eye inflammation patterns
Knowledge-focused OngoingThis study looks back at the medical records of 200 people in Singapore with eye inflammation diseases like uveitis and scleritis. Researchers want to understand who gets these conditions, what treatments they receive, and how they do over time. The goal is to learn more about th…
Matched conditions: UVEITIS
Sponsor: Singapore National Eye Centre • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:49 UTC
-
Eye fluid clues may guide uveitis treatment
Knowledge-focused OngoingThis study examines whether proteins in eye fluid can help doctors choose the right immunosuppressive drug for people with non-infectious uveitis, a type of eye inflammation. About 220 participants who haven't responded well to steroids will provide eye fluid and blood samples. R…
Matched conditions: UVEITIS
Phase: NA • Sponsor: University of Milan • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:08 UTC